Mulubwa, MwilaGriesel, Heletje AlettaMugabo, Pierre E.2020-12-152020-12-1520209. Mulubwa, M. et al (2020). Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates. Drugs in R and D ,20(2), 105-1131179-6901https://doi.org/10.1007/s40268-020-00302-7http://hdl.handle.net/10566/5516The pharmacokinetics of vancomycin, a drug used for the treatment of methicillin-resistant Staphylococcus aureus (MRSA), varies between paediatric and adult patients. The objective of this study was to assess the pharmacokinetics of vancomycin in preterm neonates and determine the optimum dose regimen.enVancomycin pharmacokineticsDose regimenPreterm NeonatesAdult patientsPaediatricArticle